Dr. Deena Midani, MD

Dr. Midani practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Midani's NPI, 1902199565, was assigned on May 16, 2011. Dr. Midani graduated from Rutgers Robert Wood Johnson Medical School in 2011. Dr. Midani holds California license A157260.

Dr. Midani's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Midani's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Dr. Midani to 1 more ambulatory surgery center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Midani practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Midani's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Midani is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Midani's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acid reflux, acute gastroduodenitis, colonoscopy, gastroenteritis, gastrointestinal bleeding, intestinal diverticulosis, irritable bowel syndrome (IBS) and upper GI endoscopy among the conditions Dr. Midani treats.

CMS data shows 610 Medicare services from Dr. Midani across 15 procedure codes in 2024, for 349 Medicare patients. Medicare paid $56,296 for them.

CMS counts 349 Medicare patients who saw Dr. Midani in 2024. The largest group is 65 to 74, with 184 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Midani's median patient age at 57, with 72% women.

In 2024, Dr. Midani wrote 560 Medicare Part D claims for 151 patients. 76% of them were for generic drugs. CMS names the drug for 438 of them, across 14 drugs with 11 or more claims each, at $80,133 in total drug cost. In 2023, CMS named 378 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Midani for performance year 2024, reported as part of a group. Dr. Midani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Midani as offering telehealth. CMS counts 101 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Midani, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Midani in 2016. 2016 was the busiest year, with 2. Dr. Midani's most frequent co-authors are Henry P. Parkman, MD, Rahul Parupalli, MD and Mohammed Saadi, MD.

CMS Open Payments shows 69 general payments to Dr. Midani from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Abbvie Inc. paid the most, $918.

Dr. Midani graduated from Rutgers Robert Wood Johnson Medical School in 2011.

Dr. Midani is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.